Huwena analgesic peptide

虎纹镇痛肽

Report date: 2022/07/19 16:22:54

Base Information

Drug NameHuwena analgesic peptide
Drug Alias NameHWAP-I
ClassificationNatural product/Extract > Animal extractBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsCancer Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSinobioway Biomedicine Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSinobioway Biomedicine Co Ltd
Inactive CompaniesN/A
Active IndicationsCancer Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A